Deborah M. Autor insider trades: Hims & Hers Health (HIMS) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Deborah reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 18, 2026 | HIMS | ↓ Sell | 16,773 | $27.85 | $467K | Direct | Aug 20, 2026 (2d) |
| May 11, 2026 | AMRX | ↓ Sell | 34,819 | $12.94 | $451K | Direct | May 12, 2026 (1d) |
| Dec 17, 2025 | HIMS | ↓ Sell | 7,054 | $36.71 | $259K | Direct | Dec 18, 2025 (1d) |
| Nov 22, 2024 | AMRX | ↓ Sell | 40,000 | $8.35 | $334K | Direct | Nov 25, 2024 (3d) |
| May 17, 2024 | AMRX | ↓ Sell | 38,000 | $6.74 | $256K | Direct | May 20, 2024 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other HIMS insiders
Open-market trades in the last 12 months
About Deborah M. Autor's insider trades
Deborah M. Autor is Chief Policy Officer at Hims & Hers Health (HIMS). Since May 17, 2024, Deborah has reported no open-market purchases and 5 sales worth $1.8M on SEC Form 4. In the last 12 months: 3 sales ($1.2M).
Their filings also include grants and awards (11 filings), option exercises (9 filings), shares withheld for taxes (2 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every HIMS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.